| |
Non-ART (n=10) |
differences* p |
ART (n=10) |
| Age (years) |
46 (38-55) |
n.s. |
46 (42-52) |
| Males : females |
9 : 1 |
n.s |
10 : 0 |
| Estimated time from seroconversion (months) |
30 (22-40) |
0.005 |
117 (114-136) |
| Time HIV seropositive (months) |
31 (15-44) |
0.02 |
102 (46-120) |
| Nadir CD4+ T lymphocyte count (cells/μl) |
n.a. |
|
190 (170-230) |
| Time from nadir (months) |
n.a. |
|
56 (22-83) |
| Time on ART (months) |
n.a. |
|
55 (27-81) |
| CD4+ T cells (cells/μl) |
710 (550-840) |
n.s. |
535 (390-690) |
| CD8+ T cells (cells/μl) |
1313 (1195-2115) |
0.004 |
880 (705-1140) |
| HIV RNA (copies/ml) |
25000 (5400-64500) |
<0.001 |
<50 (<50 - <50) |
| β2-microglobulin (%) |
1.7 (1.6-2.7) |
0.012 |
1.3 (1.1-1.5) |
| IgG |
15.4 (12.1-22.1) |
0.01 |
11.0 (8.9-12.4) |
| CD38+ fraction of CD8+ T cells (%) |
65 (61-74) |
0.001 |
35 (28-41) |
| CD28+ fraction of CD8+ T cells (%) |
24 (15-26) |
0.045 |
42 (29-56) |
* Mann-Whitney U Test